RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells

Biochemical and Biophysical Research Communications

Volumn 375, Issue 4, 2008, Pages 628-633

  Shan, Peiren ^a   Pu, Jun ^a   Yuan, Ancai ^a   Shen, Lan ^a   Shen, Linhong ^a   Chai, Dajun ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Catalase; Mitochondria; Oxidative stress; Retinoid X receptor

Indexed keywords

ALITRETINOIN; BEXAROTENE; CASPASE 3; CATALASE; CYTOCHROME C; HX 531; HYDROGEN PEROXIDE; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CYTOCHROMES C; HEART VENTRICLES; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RETINOID X RECEPTORS; TETRAHYDRONAPHTHALENES; TRETINOIN;

RATTUS;

EID: 51449103182     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.074     Document Type: Article

References (21)

1. Gill C., Mestril R., and Samali A. Losing heart: the role of apoptosis in heart disease-a novel therapeutic target?. FASEB J. 16 (2002) 135-146
2. Takemura G., and Fujiwara H. Morphological aspects of apoptosis in heart diseases. J. Cell. Mol. Med. 10 (2006) 56-75
3. Szanto A., Narkar V., Shen Q., Uray I.P., Davies P.J., and Nagy L. Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ. 11 Suppl. 2 (2004) S126-S143
4. Honda M., Hamazaki T.S., Komazaki S., Kagechika H., Shudo K., and Asashima M. RXR agonist enhances the differentiation of cardiomyocytes derived from embryonic stem cells in serum-free conditions. Biochem. Biophys. Res. Commun. 333 (2005) 1334-1340
5. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., and Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 (2000) 2140-2144
6. Chai D., Wang B., Shen L., Pu J., Zhang X.K., and He B. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic. Biol. Med. 44 (2008) 1334-1347
7. Han H., Long H., Wang H., Wang J., Zhang Y., and Wang Z. Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H2169-H2182
8. Allegretto E.A. Detection of RARs and RXRs in cells and tissues using specific ligand-binding assays and ligand-binding immunoprecipitation techniques. Methods Mol. Biol. 89 (1998) 219-232
9. Aubry J.P., Blaecke A., Lecoanet-Henchoz S., Jeannin P., Herbault N., Caron G., Moine V., and Bonnefoy J.Y. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 37 (1999) 197-204
10. Modrak D.E., Cardillo T.M., Newsome G.A., Goldenberg D.M., and Gold D.V. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res. 64 (2004) 8405-8410
11. Cen H., Mao F., Aronchik I., Fuentes R.J., and Firestone G.L. DEVD-NucView488: a novel class of enzyme substrates for real-time detection of caspase-3 activity in live cells. FASEB J. 22 (2008) 2243-2252
12. Montessuit C., Papageorgiou I., and Lerch R. Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture. Endocrinology 149 (2008) 1064-1074
13. Kim H.T., Kong G., Denardo D., Li Y., Uray I., Pal S., Mohsin S., Hilsenbeck S.G., Bissonnette R., Lamph W.W., Johnson K., and Brown P.H. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays. Cancer Res. 66 (2006) 12009-12018
14. Cohen G.M., Sun X.M., Snowden R.T., Dinsdale D., and Skilleter D.N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286 (1992) 331-334
15. Manzano V.M., Munoz J.C., Jimenez J.R., Puyol M.R., Puyol D.R., Kitamura M., and Cazana F.J.L. Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid. Br. J .Pharmacol. 131 (2000) 1673-1683
16. Rasooly R., Schuster G.U., Gregg J.P., Xiao J.H., Chandraratna R.A., and Stephensen C.B. Retinoid X receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes. J. Immunol. 175 (2005) 7916-7929
17. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1 (2001) 181-193
18. Jiménez-Lara A.M., Clarke N., Altucci L., and Gronemeyer H. Retinoic-acid-induced apoptosis in leukemia cells. Trends Mol. Med. 10 (2004) 508-515
19. Suleiman M.S., Halestrap A.P., and Griffiths E.J. Mitochondria: a target for myocardial protection. Pharmacol. Ther. 89 (2001) 29-46
20. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 (2000) 1001-1014
21. Pu J., He B., and Zhang Y. Effect of retinoid X receptor agonist on arterial reactivity and ventricular hypertrophy in spontaneously hypertensive rats. Hypertension 48 (2006) E56 (abstract)